MMR-话题@MedSci

#MMR#

44篇内容 | 1104人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1555892, encodeId=4bfb1555892b2, content=<a href='/topic/show?id=28c512040bb' target=_blank style='color:#2F92EE;'>#MMR#</a>, objectTitle=MSI-H/dMMR晚期实体瘤：各家PD-1/PD-L1表现如何？, objectType=article, longId=203620, objectId=e4af20362026, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4af20362026, replyNumber=0, likeNumber=33, createdTime=2020-11-23, rootId=0, userName=vividelife, userId=dde614671787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4af20362026, moduleTitle=MSI-H/dMMR晚期实体瘤：各家PD-1/PD-L1表现如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e4af20362026)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555891, encodeId=fcb0155589123, content=<a href='/topic/show?id=28c512040bb' target=_blank style='color:#2F92EE;'>#MMR#</a>, objectTitle=Br J Cancer：错配修复不足的转移性结直肠癌dMMR mCRC患者的生存分析, objectType=article, longId=202147, objectId=30ba20214e5d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30ba20214e5d, replyNumber=0, likeNumber=29, createdTime=2020-10-17, rootId=0, userName=vividelife, userId=dde614671787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30ba20214e5d, moduleTitle=Br J Cancer：错配修复不足的转移性结直肠癌dMMR mCRC患者的生存分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30ba20214e5d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555890, encodeId=709c15558909f, content=<a href='/topic/show?id=28c512040bb' target=_blank style='color:#2F92EE;'>#MMR#</a>, objectTitle=麻疹、腮腺炎和风疹疫苗（MMR）保护一线医护人员免受COVID-19侵害？, objectType=article, longId=200671, objectId=c2322006e112, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2322006e112, replyNumber=0, likeNumber=25, createdTime=2020-09-16, rootId=0, userName=vividelife, userId=dde614671787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2322006e112, moduleTitle=麻疹、腮腺炎和风疹疫苗（MMR）保护一线医护人员免受COVID-19侵害？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c2322006e112)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555889, encodeId=629f155588917, content=<a href='/topic/show?id=28c512040bb' target=_blank style='color:#2F92EE;'>#MMR#</a>, objectTitle=麻疹、腮腺炎和风疹疫苗（MMR）能否保护一线医护人员免受COVID-19侵害？, objectType=article, longId=200313, objectId=423a200313d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=423a200313d6, replyNumber=0, likeNumber=32, createdTime=2020-09-07, rootId=0, userName=vividelife, userId=dde614671787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=423a200313d6, moduleTitle=麻疹、腮腺炎和风疹疫苗（MMR）能否保护一线医护人员免受COVID-19侵害？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=423a200313d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555888, encodeId=3a921555888c2, content=<a href='/topic/show?id=28c512040bb' target=_blank style='color:#2F92EE;'>#MMR#</a>, objectTitle=Eur J Hum Genet：丁培荣教授解说林奇综合征初筛结果为MSI-H/dMMR，下一步该做什么检测？, objectType=article, longId=197997, objectId=6efc19e99773, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6efc19e99773, replyNumber=0, likeNumber=36, createdTime=2020-07-26, rootId=0, userName=vividelife, userId=dde614671787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6efc19e99773, moduleTitle=Eur J Hum Genet：丁培荣教授解说林奇综合征初筛结果为MSI-H/dMMR，下一步该做什么检测？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6efc19e99773)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555887, encodeId=26b0155588eb3, content=<a href='/topic/show?id=28c512040bb' target=_blank style='color:#2F92EE;'>#MMR#</a>, objectTitle=FDA批准Keytruda作为MSI-H / dMMR转移性结直肠癌的一线疗法, objectType=article, longId=196815, objectId=70ef1968157f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70ef1968157f, replyNumber=0, likeNumber=23, createdTime=2020-07-02, rootId=0, userName=vividelife, userId=dde614671787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70ef1968157f, moduleTitle=FDA批准Keytruda作为MSI-H / dMMR转移性结直肠癌的一线疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70ef1968157f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555886, encodeId=c4371555886fb, content=<a href='/topic/show?id=28c512040bb' target=_blank style='color:#2F92EE;'>#MMR#</a>, objectTitle=ASCO 2020 | Pembrolizumab或替代化疗在MSI-H / dMMR CRC中一线治疗的地位, objectType=article, longId=195301, objectId=db5919530147, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db5919530147, replyNumber=0, likeNumber=31, createdTime=2020-06-06, rootId=0, userName=vividelife, userId=dde614671787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db5919530147, moduleTitle=ASCO 2020 | Pembrolizumab或替代化疗在MSI-H / dMMR CRC中一线治疗的地位, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db5919530147)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555885, encodeId=a25e15558850d, content=<a href='/topic/show?id=28c512040bb' target=_blank style='color:#2F92EE;'>#MMR#</a>, objectTitle=MSI/MMR检测在胃肠肿瘤中的临床意义及价值, objectType=article, longId=173278, objectId=104f1e32787d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=104f1e32787d, replyNumber=0, likeNumber=26, createdTime=2019-06-28, rootId=0, userName=vividelife, userId=dde614671787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=104f1e32787d, moduleTitle=MSI/MMR检测在胃肠肿瘤中的临床意义及价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=104f1e32787d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555884, encodeId=2660155588431, content=<a href='/topic/show?id=28c512040bb' target=_blank style='color:#2F92EE;'>#MMR#</a>, objectTitle=欧洲卫生官员：去看世界杯前别忘了打MMR疫苗, objectType=article, longId=140827, objectId=98ab14082edb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=98ab14082edb, replyNumber=0, likeNumber=0, createdTime=2018-06-16, rootId=0, userName=vividelife, userId=dde614671787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=98ab14082edb, moduleTitle=欧洲卫生官员：去看世界杯前别忘了打MMR疫苗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=98ab14082edb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555883, encodeId=1990155588368, content=<a href='/topic/show?id=28c512040bb' target=_blank style='color:#2F92EE;'>#MMR#</a>, objectTitle=Oncologist：一例dMMR及种系BRAC1突变子宫内膜癌患者使用帕博利珠单抗达到完全缓解的病例报告, objectType=article, longId=131804, objectId=238713180436, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=238713180436, replyNumber=0, likeNumber=0, createdTime=2018-03-09, rootId=0, userName=vividelife, userId=dde614671787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=238713180436, moduleTitle=Oncologist：一例dMMR及种系BRAC1突变子宫内膜癌患者使用帕博利珠单抗达到完全缓解的病例报告, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=238713180436)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555882, encodeId=70e41555882bf, content=<a href='/topic/show?id=28c512040bb' target=_blank style='color:#2F92EE;'>#MMR#</a>, objectTitle=J Clin Oncol:CheckMate 142研究：dMMR/MSI-H 型mCRC的联合免疫治疗时代, objectType=article, longId=127483, objectId=749e12e48327, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=749e12e48327, replyNumber=0, likeNumber=32, createdTime=2018-01-25, rootId=0, userName=vividelife, userId=dde614671787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=749e12e48327, moduleTitle=J Clin Oncol:CheckMate 142研究：dMMR/MSI-H 型mCRC的联合免疫治疗时代, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=749e12e48327)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555881, encodeId=3256155588181, content=<a href='/topic/show?id=28c512040bb' target=_blank style='color:#2F92EE;'>#MMR#</a>, objectTitle=JAMA Oncology：DNA错配修复（MMR）状态能否预测III期结肠癌患者的预后？, objectType=article, longId=116304, objectId=d9c8116304cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9c8116304cc, replyNumber=0, likeNumber=0, createdTime=2017-10-17, rootId=0, userName=vividelife, userId=dde614671787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9c8116304cc, moduleTitle=JAMA Oncology：DNA错配修复（MMR）状态能否预测III期结肠癌患者的预后？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d9c8116304cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555880, encodeId=2452155588094, content=<a href='/topic/show?id=28c512040bb' target=_blank style='color:#2F92EE;'>#MMR#</a>, objectTitle=NEJM：第3剂MMR疫苗在腮腺炎流行期的疾病预防作用, objectType=article, longId=112250, objectId=af5f11225062, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af5f11225062, replyNumber=0, likeNumber=0, createdTime=2017-09-09, rootId=0, userName=vividelife, userId=dde614671787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af5f11225062, moduleTitle=NEJM：第3剂MMR疫苗在腮腺炎流行期的疾病预防作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af5f11225062)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555879, encodeId=59fc15558e9de, content=<a href='/topic/show?id=28c512040bb' target=_blank style='color:#2F92EE;'>#MMR#</a>, objectTitle=Lancet Oncol：纳武单抗用于dMMR/MSI-H转移性结直肠癌显示出了令人鼓舞的疗效, objectType=article, longId=107084, objectId=001f10e0841a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=001f10e0841a, replyNumber=0, likeNumber=54, createdTime=2017-07-30, rootId=0, userName=vividelife, userId=dde614671787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=001f10e0841a, moduleTitle=Lancet Oncol：纳武单抗用于dMMR/MSI-H转移性结直肠癌显示出了令人鼓舞的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=001f10e0841a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555878, encodeId=327b15558e8d8, content=<a href='/topic/show?id=28c512040bb' target=_blank style='color:#2F92EE;'>#MMR#</a>, objectTitle=Lancet Haematol：MMR稳定慢性粒细胞白血病患者TKI降阶梯治疗是否可行？, objectType=article, longId=105907, objectId=926910590ebd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=926910590ebd, replyNumber=0, likeNumber=41, createdTime=2017-07-20, rootId=0, userName=vividelife, userId=dde614671787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=926910590ebd, moduleTitle=Lancet Haematol：MMR稳定慢性粒细胞白血病患者TKI降阶梯治疗是否可行？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=926910590ebd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555877, encodeId=3a1d15558e73a, content=<a href='/topic/show?id=28c512040bb' target=_blank style='color:#2F92EE;'>#MMR#</a>, objectTitle=Science：MMR疫苗引发自闭症，这一假新闻我们还要纠缠多久？, objectType=article, longId=97551, objectId=110c9e5517a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=110c9e5517a, replyNumber=0, likeNumber=38, createdTime=2017-04-30, rootId=0, userName=vividelife, userId=dde614671787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=110c9e5517a, moduleTitle=Science：MMR疫苗引发自闭症，这一假新闻我们还要纠缠多久？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=110c9e5517a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555876, encodeId=611315558e6a4, content=<a href='/topic/show?id=28c512040bb' target=_blank style='color:#2F92EE;'>#MMR#</a>, objectTitle=MMWR：暴发腮腺炎是否需要再来一针MMR，尚无定论, objectType=article, longId=75223, objectId=27bce5223a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27bce5223a2, replyNumber=0, likeNumber=38, createdTime=2016-08-17, rootId=0, userName=vividelife, userId=dde614671787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27bce5223a2, moduleTitle=MMWR：暴发腮腺炎是否需要再来一针MMR，尚无定论, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27bce5223a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555875, encodeId=0db615558e501, content=<a href='/topic/show?id=28c512040bb' target=_blank style='color:#2F92EE;'>#MMR#</a>, objectTitle=CDD：激活p53的小分子MMRi化合物可能成为癌症潜在药物, objectType=article, longId=62792, objectId=e75762e9282, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e75762e9282, replyNumber=0, likeNumber=34, createdTime=2016-02-02, rootId=0, userName=vividelife, userId=dde614671787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e75762e9282, moduleTitle=CDD：激活p53的小分子MMRi化合物可能成为癌症潜在药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e75762e9282)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555874, encodeId=247515558e4b3, content=<a href='/topic/show?id=28c512040bb' target=_blank style='color:#2F92EE;'>#MMR#</a>, objectTitle=PNAS：如何提高MMR疫苗接种率？宣教内容很重要, objectType=article, longId=54483, objectId=f028544838f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f028544838f, replyNumber=0, likeNumber=28, createdTime=2015-08-07, rootId=0, userName=vividelife, userId=dde614671787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f028544838f, moduleTitle=PNAS：如何提高MMR疫苗接种率？宣教内容很重要, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f028544838f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555873, encodeId=30e115558e37a, content=<a href='/topic/show?id=28c512040bb' target=_blank style='color:#2F92EE;'>#MMR#</a>, objectTitle=JAMA：MMR疫苗可降低感染住院率, objectType=article, longId=31933, objectId=f9033193382, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9033193382, replyNumber=0, likeNumber=24, createdTime=2014-03-16, rootId=0, userName=vividelife, userId=dde614671787, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9033193382, moduleTitle=JAMA：MMR疫苗可降低感染住院率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9033193382)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

MMR

2020-05-29

vividelife (审核中...)

前往app查看评论内容

#MMR#

MSI-H/dMMR晚期实体瘤：各家PD-1/PD-L1表现如何？

2020-11-23

vividelife (审核中...)

前往app查看评论内容

#MMR#

Br J Cancer：错配修复不足的转移性结直肠癌dMMR mCRC患者的生存分析

2020-10-17

vividelife (审核中...)

前往app查看评论内容

#MMR#

麻疹、腮腺炎和风疹疫苗（MMR）保护一线医护人员免受COVID-19侵害？

2020-09-16

vividelife (审核中...)

前往app查看评论内容

#MMR#

麻疹、腮腺炎和风疹疫苗（MMR）能否保护一线医护人员免受COVID-19侵害？

2020-09-07

vividelife (审核中...)

前往app查看评论内容

#MMR#

Eur J Hum Genet：丁培荣教授解说林奇综合征初筛结果为MSI-H/dMMR，下一步该做什么检测？

2020-07-26

vividelife (审核中...)

前往app查看评论内容

#MMR#

FDA批准Keytruda作为MSI-H / dMMR转移性结直肠癌的一线疗法

2020-07-02

vividelife (审核中...)

前往app查看评论内容

#MMR#

ASCO 2020 | Pembrolizumab或替代化疗在MSI-H / dMMR CRC中一线治疗的地位

2020-06-06

vividelife (审核中...)

前往app查看评论内容

#MMR#

MSI/MMR检测在胃肠肿瘤中的临床意义及价值

2019-06-28

vividelife (审核中...)

前往app查看评论内容

#MMR#

欧洲卫生官员：去看世界杯前别忘了打MMR疫苗

2018-06-16

vividelife (审核中...)

前往app查看评论内容

#MMR#

Oncologist：一例dMMR及种系BRAC1突变子宫内膜癌患者使用帕博利珠单抗达到完全缓解的病例报告

2018-03-09

vividelife (审核中...)

前往app查看评论内容

#MMR#

J Clin Oncol:CheckMate 142研究：dMMR/MSI-H 型mCRC的联合免疫治疗时代

2018-01-25

vividelife (审核中...)

前往app查看评论内容

#MMR#

JAMA Oncology：DNA错配修复（MMR）状态能否预测III期结肠癌患者的预后？

2017-10-17

vividelife (审核中...)

前往app查看评论内容

#MMR#

NEJM：第3剂MMR疫苗在腮腺炎流行期的疾病预防作用

2017-09-09

vividelife (审核中...)

前往app查看评论内容

#MMR#

Lancet Oncol：纳武单抗用于dMMR/MSI-H转移性结直肠癌显示出了令人鼓舞的疗效

2017-07-30

vividelife (审核中...)

前往app查看评论内容

#MMR#

Lancet Haematol：MMR稳定慢性粒细胞白血病患者TKI降阶梯治疗是否可行？

2017-07-20

vividelife (审核中...)

前往app查看评论内容

#MMR#

Science：MMR疫苗引发自闭症，这一假新闻我们还要纠缠多久？

2017-04-30

vividelife (审核中...)

前往app查看评论内容

#MMR#

MMWR：暴发腮腺炎是否需要再来一针MMR，尚无定论

2016-08-17

vividelife (审核中...)

前往app查看评论内容

#MMR#

CDD：激活p53的小分子MMRi化合物可能成为癌症潜在药物

2016-02-02

vividelife (审核中...)

前往app查看评论内容

#MMR#

PNAS：如何提高MMR疫苗接种率？宣教内容很重要

2015-08-07

vividelife (审核中...)

前往app查看评论内容

#MMR#

JAMA：MMR疫苗可降低感染住院率

2014-03-16

科室
- - 订阅+
  - 更多科室
工具
服务